Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats

Journal of the American Society of Nephrology

Volumn 17, Issue 3, 2006, Pages 655-662

  Odenwald, Tobias ^a   Nakagawa, Kumiko ^a   Hadtstein, Charlotte ^a   Roesch, Frank ^b   Gohlke, Peter ^c   Ritz, Eberhard ^a   Schaefer, Franz ^a   Schmitt, Claus Peter ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIMIMETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; R 568; SODIUM; SOLVENT; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DEVICE; DRUG EFFECT; DRUG INFUSION; ENZYME ACTIVITY; FOOD INTAKE; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MINERAL METABOLISM; NEPHRECTOMY; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RAT; SODIUM BLOOD LEVEL; TELEMETRY; UREMIA;

EID: 33645459663     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005090914     Document Type: Article

References (23)

1. Ogata H, Ritz E, Odoni G, Amann K, Orth SR: Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 14: 959-967, 2003
2. Goodman WG, Hladik GA, Turner SA, Blaisdell PW, Goodkin DA, Liu W, Barri YM, Cohen RM, Coburn JW: The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 13: 1017-1024, 2002
3. Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ: The calcimimetic AMG 073 reduces parathyroid hormone and calcium X phosphorus in secondary hyperparathyroidism. Kidney Int 63: 248-254, 2003
4. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004
5. Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW: Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study. J Am Soc Nephrol 16: 800-807, 2005
6. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT, Antignac C: Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 13: 2259-2266, 2002
7. Unger T, Gohlke P: ACE inhibition in the tissues. Clin Physiol Biochem 9: 89-93, 1992
8. Vecsei P, Abdelhamid S, Mittelstadt GV, Lichtwald K, Haack D, Lewicka S: Aldosterone metabolites and possible aldosterone precursors in hypertension. J Steroid Biochem 19: 345-351, 1983
9. Abraham GE, Buster JE, Lucas LA, Corrales PC, Teller RC: Chromatographic separation of steroid hormones for use in radioimmunoassays. Anal Lett 5: 509-517, 1972
10. Yasumura S, Jones K, Spanne P, Schidlovsky G, Wielopolski L, Ren X, Glaros D, Xatzikonstantinou Y: In vivo animal models of body composition in aging. J Nutr 123: 459-464, 1993
11. Ohanian J, Gatfield KM, Ward DT, Ohanian V: Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries. Am J Physiol Heart Circ Physiol 288: H1756-H1762, 2005
12. Bukoski RD, Bian K, Wang Y, Mupanomunda M: Perivascular sensory nerve Ca2+ receptor and Ca2+-induced relaxation of isolated arteries. Hypertension 30: 1431-1439, 1997
13. Wang Y, Bukoski RD: Distribution of the perivascular nerve Ca2+ receptor in rat arteries. Br J Pharmacol 125: 1397-1404, 1998
14. Ishioka N, Bukoski RD: A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation. J Pharmacol Exp Ther 289: 245-250, 1999
15. Iseki K, Massry SG, Campese VM: Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal-failure rats. Am J Physiol 250: F924-F929, 1986
16. Hulter HN, Melby JC, Peterson JC, Cooke CR: Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 2: 360-370, 1986
17. Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, Ritz E: Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 12: 933-938, 1997
18. Mann JF, Wiecek A, Bommer J, Ganten U, Ritz E: Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 45: 46-52, 1987
19. Rybczynska A, Boblewski K, Lehmann A, Orlewska C, Foks H, Drewnowska K, Hoppe A: Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 18: 364-371, 2005
20. Ye C, Kanazirska M, Quinn S, Brown EM, Vassilev PM: Modulation by polycationic Ca(2+)-sensing receptor agonists of nonselective cation channels in rat hippocampal neurons. Biochem Biophys Res Commun 224: 271-280, 1996
21. Rogers KV, Dunn CK, Hebert SC, Brown EM: Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization. Brain Res 744: 47-56, 1997
22. Rothe HM, Sun WY, Shapiro WB, Mayer G, Matalon A: Response to a single dose of cinacalcet in relation to calcium-sensing receptor gene polymorphism ARG990GLY [Abstract]. Nephron 10: 14, 2005
23. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P: An investigation of the effect of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant 12: 2301-2307, 1997